Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024

NCT07091734 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Lipodystrophy, Partial

Interventions

DRUG: Tirzepatide
DRUG: Usual care medications

Sponsor

University of Michigan